Detalhe da pesquisa
1.
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.
Nat Immunol
; 24(2): 255-266, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658237
2.
ILC1s control leukemia stem cell fate and limit development of AML.
Nat Immunol
; 23(5): 718-730, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487987
3.
Publisher Correction: ILC1s control leukemia stem cell fate and limit development of AML.
Nat Immunol
; 23(8): 1286, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705798
4.
Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.
Trends Immunol
; 43(10): 833-847, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058806
5.
PDGF-D-PDGFRß signaling enhances IL-15-mediated human natural killer cell survival.
Proc Natl Acad Sci U S A
; 119(3)2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027451
6.
Adipocyte CD1d Gene Transfer Induces T Cell Expansion and Adipocyte Inflammation in CD1d Knockout Mice.
J Immunol
; 208(9): 2109-2121, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418470
7.
Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer.
Gastroenterology
; 162(4): 1319-1333, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999097
8.
Application of natural killer immunotherapy in blood cancers and solid tumors.
Curr Opin Oncol
; 35(5): 446-452, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37551952
9.
Recent Advances of RNA m6A Modifications in Cancer Immunoediting and Immunotherapy.
Cancer Treat Res
; 190: 49-94, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112999
10.
Targeting the RNA m6A modification for cancer immunotherapy.
Mol Cancer
; 21(1): 76, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296338
11.
Long-term prognostic significance of interleukin-17-producing T cells in patients with non-small cell lung cancer.
Cancer Sci
; 110(7): 2100-2109, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100180
12.
Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple Myeloma.
Cell Physiol Biochem
; 45(4): 1631-1640, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29486474
13.
IL-1ß and TLR4 signaling are involved in the aggravated murine acute graft-versus-host disease caused by delayed bortezomib administration.
J Immunol
; 192(3): 1277-85, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24363427
14.
Recent advances and remaining challenges in lung cancer therapy.
Chin Med J (Engl)
; 137(5): 533-546, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321811
15.
The tumor-intrinsic role of the m6A reader YTHDF2 in regulating immune evasion.
Sci Immunol
; 9(95): eadl2171, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820140
16.
Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non-Small Cell Lung Cancer.
Cancer Immunol Res
; 12(6): 731-743, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572955
17.
Harnessing Natural Killer Cells for Lung Cancer Therapy.
Cancer Res
; 83(20): 3327-3339, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531223
18.
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells.
Sci Immunol
; 8(81): eabn7993, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897958
19.
Off-the-shelf CAR-engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia.
Blood Adv
; 7(20): 6225-6239, 2023 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379267
20.
A four-stage model for murine natural killer cell development in vivo.
J Hematol Oncol
; 15(1): 31, 2022 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313938